Am Thyrovision Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.28 M
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 M
- Satisfied Charges ₹ 0.85 M
- Revenue Growth 59.04%
- Profit Growth 213.08%
- Ebitda 48.33%
- Net Worth 40.58%
- Total Assets 12.57%
About Am Thyrovision Laboratories
Am Thyrovision Laboratories Private Limited (ATLPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 December 2005 and has a history of 19 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.28 M.
The company currently has active open charges totaling ₹4.50 M. The company has closed loans amounting to ₹0.85 M, as per Ministry of Corporate Affairs (MCA) records.
Satya Gupta and Anju Mishra serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85195DL2005PTC143352
- Company No.
143352
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2005
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Healthcare
Who are the key members and board of directors at Am Thyrovision Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satya Gupta  | Director | 06-Dec-2005 | Current |
| Anju Mishra | Director | 06-Dec-2005 | Current |
Financial Performance of Am Thyrovision Laboratories.
Am Thyrovision Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.04% increase. The company also saw a substantial improvement in profitability, with a 213.08% increase in profit. The company's net worth Soared by an impressive increase of 40.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Am Thyrovision Laboratories?
In 2023, Am Thyrovision Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹4.50 M
Satisfied Charges
₹0.85 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jan 2021 | Hdfc Bank Limited | ₹4.50 M | Open |
| 22 May 2012 | Siemens Financial Services Private Limited | ₹0.85 M | Satisfied |
How Many Employees Work at Am Thyrovision Laboratories?
Am Thyrovision Laboratories has a workforce of 7 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Am Thyrovision Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Am Thyrovision Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
